TAFAZZIN and cardiomyopathy: In fact, mutations in tafazzin (TAZ), a mitochondrial phospholipid-lysophospholipid transacylase that participates in CL remodeling, are implicated in Barth syndrome, in which patients lacking functional TAZ present with cardiomyopathy and skeletal dysfunction due to a total CL deficiency.